Best Practice
Multiply your time with significance

“How is it that we have more tips, tricks, tools, technology, calendars and checklists than ever before, and yet we still always seem to be behind?” asks Rory Vaden, a leadership consultant and author of Take The Stairs.
“It’s because everything you know about time management is wrong.”
Most of us manage our time by writing to-do lists and prioritising the items on those lists. We decide our priorities by assessing the urgency and importance of our tasks.
There is now a third criteria considered by “time multipliers” – significance. Rather than asking ‘What’s the most important thing I can do today’, time multipliers ask ‘What’s the most important thing I can do today that would make tomorrow better?’
Rory Vaden has dedicated his entire life to the study of leadership and influence. His education and experience took him all the way from being raised by a single mother in a trailer park to becoming a New York Times bestselling author, a world renowned Hall of Fame keynote speaker, and an Eight-Figure entrepreneur.
He has developed dozens of insights, frameworks and methodologies that led to a viral Ted talk and have been used by some of the most successful organisations in the world to mobilise their sales forces, develop their leaders and move their people into action.
Register FREE and join 20,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.
You may also like 10 Tips to enhance your self-motivation
News & Trends - MedTech & Diagnostics

Sussan Ley breaks ground as first female opposition leader amid Liberal party shake-up
Sussan Ley has made history as the country’s first female opposition leader, edging out former shadow treasurer Angus Taylor in […]
MoreNews & Trends - MedTech & Diagnostics

New procedure shows durable impact in type 2 diabetes
Medtech company, Endogenex, has unveiled promising data from an Australian clinical trial that could mark a turning point in type […]
MoreNews & Trends - Pharmaceuticals

AI rewrites the script on androgen deprivation therapy in prostate cancer
Artificial intelligence is showing promise in reshaping treatment decisions for men undergoing radiation therapy and androgen deprivation therapy (ADT) for […]
MoreNews & Trends - MedTech & Diagnostics

MSAC to assess CGM funding for expanded access in diabetes management
Applications from Abbott Australasia and Australasian Medical & Scientific Limited (AMSL) for public funding of continuous glucose monitoring (CGM) devices […]
More